HIV/AIDS Vaccine
Polyvalent DNA prime/protein boost HIV-1 vaccine is immunogenic and safe
Published in AIDS Weekly, April 24th, 2006
According to recent research from the United States, "A toxicity and immunogenicity study, evaluating the safety of a polyvalent DNA prime/protein boost HIV-1 vaccine (DP6-001), was examined in rabbits.
"Animals were primed with a cocktail of six different DNA plasmids expressing five HIV-1 env genes and one gag gene followed by boosting with five gp120 proteins homologous to the DNA vaccines."
"The vaccine was shown to be immunogenic as evident from the induction of high-titered anti-Env and anti-Gag antibodies. There was an absence of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2006-04-24)
More Articles from AIDS Weekly
- HIV/AIDS Drug Development
HIV infection inhibited by soluble mimic of globotriaosyl ceramide analogue - HIV/AIDS HAART
Enfuvirtide once-daily dose bioequivalent to twice-daily dose but has lower antiviral activity - HIV/AIDS Prognostic Indicators
Statistical model predicts HAART response from RT and protease amino acid sequence data - HIV/AIDS Transmission
Foreskin inner mucosal surface has cells that make it highly susceptible to HIV - HIV/AIDS Transmission
HIV-1 susceptibility may be influenced by DC-SIGN-related molecule polymorphisms - Cervical Cancer
Reports add new data to cervical cancer research - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
